Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Newgene Bioengineering Norge
NUF
Active
Org 985898650
Svalbardveien 1A, 0375
Oslo
Annen forskning og annet utviklingsarbeid innen naturvitenskap og teknikk
·
NACE 72190
Est. 2003 · 22 years old
0 employees
www.newgene.no
Monitor
Share
Norway
/
Companies
/
Annen forskning og annet utviklingsarbeid innen naturvitenskap og teknikk
/
Newgene Bioengineering Norge
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
0M
0M
-1M
-1M
2018: 0M
0M
2018
2019: 0M
0M
2019
2020: 0M
0M
2020
2021: 0M
0M
2021
2023: 0M
0M
2023
EBITDA
NOK millions
0M
0M
-1M
-1M
-1M
2018: 0M
0M
2018
2019: -1M
-1M
2019
2020: 0M (+100% vs 2019)
0M
2020
2021: -1M
-1M
2021
2023: 0M (+100% vs 2021)
0M
2023
Income statement
NOK thousands
Item
2023
2021
2020
2019
2018
Revenue
0
124
127
98
0
Staff expenses
−0
−413
−296
−91
−172
EBITDA
−45
−1 053
−416
−1 124
−378
Depreciation & amort.
−0
−12
−0
−0
−0
EBIT
−45
−1 065
−416
−1 124
−378
Net financials
−0
−157
−127
−140
−1
Profit before tax
−45
−1 221
−543
−1 264
−379
Tax
−0
−0
−0
−0
−0
Net profit
−45
−1 221
−543
−1 264
−379
Balance sheet
NOK thousands
Item
2023
2021
2020
2019
2018
Total assets
1
100
55
166
1 958
Equity
−1
−5 295
−4 074
−3 530
−2 266
Long-term debt
0
5 171
4 010
3 622
3 711
Short-term debt
2
224
119
75
512
Total debt
2
5 395
4 129
3 697
4 224
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2018
2023
Equity ratio
−144,4 %
This company
38,2 %
Market median
This company
Market median
478% below market
2018
2023
Return on equity
—
This company
18,4 %
Market median
This company
Market median
2018
2023
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2018
2023
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2018
2023
Debt / equity
—
This company
0,62×
Market median
This company
Market median
2018
2023
Annual reports & filings
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-06-28
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
View
PDF
More on Newgene Bioengineering Norge
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
